CXCR4 and acute respiratory distress syndrome: In conclusion, our findings suggest that the class of CXCR4 protein agonists prevent development of ARDS and reduce mortality in rats after lung ischemia–reperfusion injury and hemorrhage when administered during the early resuscitation period.